Solr Search

alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions At present, no disease-modifying therapies for the pure tauopathies exist.

ct now to prepare for this irreversible shift in demography.

em. But along with this success comes one of our greatest challenges to healthy longevity.

the performance of 352 U.S. metropolitan areas in promoting and enabling successful aging.

nd opportunities in realizing the potential of healthy, productive and purposeful aging.

g on a research project to evaluate the most pressing barr, REFERENCES

Future of Aging convened the Social Isolation Impact Summit.

ide service to others, and the broad social and economic opportunities that derive from their contributions as they age with purpose.

mpacts. New opportunities to work and contribute to society, new health costs, and persistent ageist attitudes are just a few of the implications.

ilestones and exit the labor force, questions arise: How will the traditional retirement years be financed?

diagnosis. People with vascular dementia and Lewy body dementia live on average five to six years after diagnosis.